Here is a list of the key late-breaking clinical study presentations at the 2019 American Heart Association (AHA) annual meeting, Nov. 16-18, 2019, in Philadelphia.
(February 2020 update โ the results of this trial led to the FDA clearnace of the Micra AV device in January 2020 - FDA ...
November 7, 2019 โ The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
November 7, 2019 โ Ultrasoundplasty before angioplasty for below-the-knee lesions (BTK) lesions may improve clinical ...
November 14, 2019 โ There were positive results in the TANGO Trial is a phase 2, dose escalation, double-blinded trial ...
November 14, 2019 โ More than a million Americans face a doubling in their risk of death during or while recovering from ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
November 14, 2019 โ A new study from researchers at the Smidt Heart Institute at Cedars-Sinai shows that electronic ...
November 14, 2019 โ Results were positive for the multicenter PROMISE I Trial represents the first human use in the ...
November 14, 2019 โ A large majority of patients with atherosclerotic cardiovascular disease (ASCVD) in the NCDR ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
November 7, 2019 โ The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the ...
November 14, 2019 โ The results of the 21 late-breaking clinical trials presented for the first time at Vascular ...
November 14, 2019 โ Ultromics has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
https://www.dicardiology.com/channel/pacemakersTexas Heart Institute (THI) was awarded a prestigious four-year, $2.39 million grant from the National Institutes of Health (NIH) to explore further the development of a novel pacemaker system that is both leadless and wirelessly powered.
This is a photo essay of new technologies and activities at the American Society of Nuclear Cardiology (ASNC) 2019 ...
November 7, 2019 โ The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...